AI주식인사이트AI Stock Insight
C

차AI헬스케어

025620KOSPI기타 화학제품 제조업

48.0 / 100

Reference Date: 2026-04-13

Financial Score12.5 / 40
News Sentiment12.5 / 25
Momentum11.0 / 20
Disclosure12.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Slightly down 1.0% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Cha AI Healthcare primarily engages in the development, manufacturing, and sales of skincare, makeup, and personal care products, leveraging high-performance ingredients and dermatological expertise. Aligning with global trends emphasizing sustainability and safety, the company is expanding its range of natural ingredient-based products, sensitive skin care lines, and customized beauty solutions, while pursuing global market expansion through digital channels.

Number of Employees

44people

Average Salary

45.6M KRW

Score Calculation Basis

Detailed Financial Score

PER
52.49Industry Average 18.380.0Point

2.9x industry avg (risky)

PBR
2.29Industry Average 1.371.0Point

1.7x industry avg (risky)

ROE
2.60Industry Average 4.552.5Point

Below industry avg

Debt Ratio
0.89Industry Average 8.138.0Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼30.7% (2-year basis)

Operating Profit Growth Rate
1.0 / 3

Avg ▲4.8% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -13.8% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Detailed Momentum

52-week position3.0Point

52w lower range (38%)

Current 9,500Won52-week high 16,54052-week low 5,050
1-month return3.0Point

1m -1.04% (flat)

Volume trend5.0Point

Volume flat

Detailed Disclosure

4 totalPositive 1Neutral 3Negative 0
  • Neutral정기주주총회결과2026-03-27
  • Positive단일판매ㆍ공급계약체결2026-03-20
  • Neutral감사보고서제출2026-03-19
  • Neutral사업보고서 (2025.12)2026-03-19